Emerging biologics in severe asthma

समान संसाधन

• Interleukin-5 inhibitors for severe asthma: Rationale and future outlook.
  द्वारा: Shrimanker, R, और अन्य
  प्रकाशित: (2017)
• Evidence for the efficacy and safety of anti- interleukin-5 treatment in the management of refractory eosinophilic asthma
  द्वारा: Xue, L, और अन्य
  प्रकाशित: (2015)
• Management and mechanisms of severe eosinophilic asthma
  द्वारा: Shrimanker, R
  प्रकाशित: (2020)
• Exacerbations of severe asthma in patients treated with mepolizumab
  द्वारा: Shrimanker, R, और अन्य
  प्रकाशित: (2018)
• Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
  द्वारा: Howell, I, और अन्य
  प्रकाशित: (2024)